Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.04. | Sigyn Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
10.04. | Sigyn Therapeutics, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
05.03. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference | 1 | GlobeNewswire (USA) | ||
21.02. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Filing of 2023 Annual Report on SEC Form 10-K | 1 | GlobeNewswire (USA) | ||
20.02. | Sigyn Therapeutics, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
02.02. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Completes Reverse Stock Split | 198 | GlobeNewswire (Europe) | SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: "SIGYD", "SIGY"), a development-stage medical technology company, disclosed... ► Artikel lesen | |
30.01. | Sigyn Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
30.01. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Reverse Stock Split | 189 | GlobeNewswire (Europe) | SAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced... ► Artikel lesen | |
08.01. | Sigyn Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
04.01. | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to Shareholders | 522 | GlobeNewswire (Europe) | SAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced... ► Artikel lesen | |
12.12.23 | Sigyn Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
12.12.23 | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer | 130 | GlobeNewswire (Europe) | SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced... ► Artikel lesen | |
15.11.23 | Sigyn Therapeutics Inc GAAP EPS of -$0.02 | 2 | Seeking Alpha | ||
14.11.23 | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Third Quarter 2023 Financial Results | 117 | GlobeNewswire (Europe) | SAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announces... ► Artikel lesen | |
04.10.23 | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity | 65 | GlobeNewswire (Europe) | SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today disclosed... ► Artikel lesen | |
14.08.23 | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Reports Second Quarter 2023 Financial Results | 58 | GlobeNewswire (Europe) | SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a medical technology company that creates blood purification devices to overcome... ► Artikel lesen | |
16.05.23 | Sigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial Results | 173 | GlobeNewswire (Europe) | SAN DIEGO, CA, May 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announces... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,74 | -0,38 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 38,650 | +3,29 % | AKTIEN IM FOKUS: Positiver Trend von FMC und Fresenius hält an | FRANKFURT (dpa-AFX) - Für die Papiere von Fresenius Medical Care (FMC) und Fresenius setzt sich der jüngste Aufwärtstrend am Montag fort. Die Titel des Medizinkonzerns und Krankenhausbetreibers Fresenius... ► Artikel lesen | |
FRESENIUS | 27,680 | +1,73 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,70 | +0,40 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 52,05 | +0,42 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PROGYNY | 32,540 | +1,56 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
GERRESHEIMER | 100,40 | -0,10 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
ADAPTHEALTH | 10,130 | +1,71 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
ATRICURE | 23,370 | +0,86 % | AtriCure upgraded at Oppenheimer on valuation | ||
RXSIGHT | 53,26 | +1,06 % | RxSight, Inc. - 8-K, Current Report | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 24,300 | +1,72 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,910 | +3,12 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
MIMEDX | 6,260 | -0,08 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
PRIVIA HEALTH GROUP | 18,680 | +2,24 % | Where Privia Health Gr Stands With Analysts | ||
LIFESTANCE HEALTH GROUP | 6,260 | +0,97 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2023 Results | SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |